Who owns XyloCor Therapeutics?

XyloCor Therapeutics is currently owned by Jeito Capital, through Jeito II, since 2024.

When did Jeito Capital acquire XyloCor Therapeutics?

Jeito Capital acquired XyloCor Therapeutics in 2024 (active for 2 years).

Home/Companies/Biotech/XyloCor Therapeutics

Biotech·

US·Active·2yr hold

XyloCor Therapeutics is a healthcare company, headquartered in France.

Entry

2024

Hold

2yr

Status

Active

Est. EV

–

Investor

HQFrance

SectorHealthcare

Pennsylvania-based cardiovascular gene therapy company developing AAV-based treatments for refractory angina; Jeito Capital backed in 2024.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Jeito II

6 comparable biotech deals from other GPs

Already a member? Sign in

Data refreshed weekly · Sourced from public filings